Scarica l'app Stockscreener
58.06
4.67%
2.59
Dopo l'orario di chiusura:
58.45
0.39
+0.67%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TGTX Giù?
Forum
Previsione
Frazionamento azionario
Tg Therapeutics Inc Borsa (TGTX) Ultime notizie
TGTX Maintained by B of A Securities -- Price Target Raised to $20 - GuruFocus
TG Therapeutics stock hits 52-week high at 57.4 USD - Investing.com
TG Therapeutics, Inc. Stock 12‑Month Price Target Raised to $52.14, Implies 6% Downside - TradingView
TG Therapeutics Begins Phase II Study With Briumvi in Schizophrenia - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
TGTX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $70 - GuruFocus
TG Therapeutics begins schizophrenia Phase 2 trial - grafa.com
TG Therapeutics begins trial of Briumvi for schizophrenia - Investing.com
TG Therapeutics tests BRIUMVI in 60 schizophrenia patients - Stock Titan
TG Therapeutics, Inc. (TGTX) Investor Outlook: Navigating Growth with High Potential in Biotech - DirectorsTalk Interviews
TG Therapeutics Reports First Quarter 2026 Financial Results and Raises BRIUMVI Revenue Guidance - marketscreener.com
Will Briumvi's Strength Continue to Aid TGTX's Top Line in Q2? - Yahoo Finance
TGTXTG Therapeutics Inc Dividends - Finviz
TG THERAPEUTICS INC (NASDAQ:TGTX): High-Growth Momentum Meets Minervini Trend Template Technical Strength - ChartMill
TG THERAPEUTICS INC (TGTX) Stock Chart - ChartMill
Price to sales forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
Price to earnings forward of TG Therapeutics, Inc. – MIL:1TGTX - TradingView
Does TG Therapeutics (NASDAQ:TGTX) Deserve A Spot On Your Watchlist? - Moomoo
TG Therapeutics Surged 88%: Time To Be More Careful (Rating Downgrade) (NASDAQ:TGTX) - Seeking Alpha
Responsive Playbooks and the TGTX Inflection - Stock Traders Daily
TGTX stock continues rally for 8 straight sessions on new BRIUMVI clinical data - MSN
NKB2 Forecast — Price Target — Prediction for 2027 - TradingView
TG Therapeutics (TGTX) soars 7.5%: Is further upside left in the stock? - MSN
TG Therapeutics Board Authorizes New $100M Share Repurchase Program - MSN
Price to earnings forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
Enterprise value to EBITDA forward of TG Therapeutics, Inc. – FWB:NKB2 - TradingView
Price to book forward of TG Therapeutics, Inc. – FWB:NKB2 - TradingView
Enterprise value to EBIT forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
Enterprise value to EBIT forward of TG Therapeutics, Inc. – LSX:A1JXW7 - TradingView
Price to sales forward of TG Therapeutics, Inc. – FWB:NKB2 - TradingView
Enterprise value to revenue forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
TG Therapeutics, Inc. Actuals & Estimates (NASDAQ:TGTX) - TradingView
TG Therapeutics, Inc. Actuals & Estimates (MIL:1TGTX) - TradingView
Price to earnings forward of TG Therapeutics, Inc. – LSX:A1JXW7 - TradingView
Price to sales forward of TG Therapeutics, Inc. – LSX:A1JXW7 - TradingView
TGTX Forecast — Price Target — Prediction for 2027 - TradingView
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits
TG Therapeutics Inc (TGTX) Institutional Confidence - TradingKey
TG Therapeutics Stock 10-Day Winning Spree: Stock Climbs 35% - Trefis
TG Therapeutics Stock Surges 35%, With A 10-Day Winning Spree - Trefis
Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83 - Moomoo
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth - DirectorsTalk Interviews
TG Therapeutics Stock Rockets 33% With 9-Day Winning Streak - Trefis
TG Therapeutics Stock 9-Day Winning Spree: Stock Climbs 33% - Trefis
TG Therapeutics rises on early-stage trial data for Briumvi injectable - MSN
Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now? - Insider Monkey
TG Therapeutics stock hits 52-week high at 54.04 USD By Investing.com - Investing.com Australia
TG Therapeutics Stock Surges 28%, With A 8-Day Winning Spree - Trefis
The Utter Rampage That Sent This Biotech Flying 79% - Investor's Business Daily
TG Therapeutics Stock Rises Thursday: What's Driving The Gains?TG Therapeutics (NASDAQ:TGTX) - Benzinga
TG Therapeutics Inc (TGTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TG Therapeutics stock hits 52-week high at 54.04 USD - Investing.com
TGTX stock up on positive phase I data for subcutaneous Briumvi - MSN
TG Therapeutics Inc (TGTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
TG Therapeutics Inc (TGTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TG Therapeutics Inc (TGTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TG Therapeutics Inc (TGTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TG Therapeutics Inc (TGTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):